Innovation and Commitment in Personal Mobility

iBot 3000

iBOT™ 3000

• Research and Development: 1990-2001

• Clinical Trials Started: 3/2002

• Food and Drug Administration  (FDA) Application Submitted: 7/2002

• FDA Approval Received (Class III): 8/2003

• Launch: 11/2003

• Production: 11/2003-9/2005

iBot4000

iBOT™ 4000

• Development: 2001-2004

• FDA Application Submitted: 9/2004

• FDA Approval Received (Class III): 3/2005

• Launch: 9/2005

• Production: 2005-2009

iBot PMD

iBOT™ PMD

• FDA Petition Filed for Class II Determination: 10/2012

• FDA Hearings: 12/2013

• FDA Class II Determination: 4/2014

• Development: 2014-ongoing

• FDA Clearance: 2/2018

• Mobius Mobility Start-Up: 3/2018

• Expected Launch: 3Q 2019